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Abstract 1 
Providing the neonatal calf with a sufficient quantity and quality of colostrum may optimise future 2 
health, performance and reduce the risk of morbidity. A 6-month double blind trial with 80 prepartum 3 
dairy cows was conducted to determine if supplementation with mannan oligosaccharide (MOS) 4 
influences colostrum quality, quantity and subsequent calf performance. The Holstein cross Friesian 5 
80 cows (no heifers) were allocated into a control and treatment group at the point of drying off by 6 
previous lactation number and yield. The control and treatment group were fed the same commercial 7 
standard dry cow diet throughout the trial supplemented with a mineral concentrate without or with 8 
1.33% MOS, respectively. Cows were milked out of colostrum within 40 min of calving prior to calf 9 
suckling, weight was recorded. Mannan oligosaccharide fed cows produced significantly more 10 
colostrum on first milking (7.5 kg, SEM±0.69) compared with cows fed without MOS (5.6 kg, 11 
SEM±0.43). The immunoglobulin G (IgG) concentrations (control 53.7 IgG g/l, SEM±5.8 and MOS 12 
of 42.7 IgG g/l, SEM±4.9) and total mass of IgG did not differ between treatments. No significant 13 
observable MOS-derived effect on calf health or weight gain occurred during the study. 14 
 15 
Implications 16 
Mannan oligosaccharides (MOS) are a yeast-based by-product which may enhance gastrointestinal 17 
conditions and overall animal health, resulting in improved animal performance. In dairy cows, MOS 18 
prepartum supplementation increases colostrum quantity which could improve future calf 19 
performance. 20 
 21 
Introduction 22 
Colostrum is the primary source of immunoglobulins and nutrients essential for neonatal calf survival 23 
as the bovine placenta inhibits the transfer of immunoglobulins and essential vitamins (Quigley and 24 
Drewry, 1998). Immunoglobulins G (IgG) account for up to 85% of the immune proteins and is the 25 
most predominant immunoglobulin found in the intestine of the calf (Butler, 1983). Colostral IgG 26 
concentration and yield can vary greatly between individual cows and is influenced by a number of 27 
factors including parity number, time interval from calving to first milking and colostral weight 28 
(Conneely et al., 2013). In a study of 704 Irish dairy cows, colostral IgG concentrations ranged from 29 
13 up to 256 g/l, with increasing colostral weight having a negative effect on IgG concentrations 30 
(Conneely et al., 2013). 31 
 32 
The European Union ban on antibiotics as growth promoters in animal feed supplements in 2006 and 33 
in calf milk replacers in 2013 has intensified the need to improve the quality and quantity of 34 
colostrum produced to promote calf performance (Conneely et al., 2014). Alternatives such as 35 
probiotics are being examined to determine their suitability to inhibit the activity of pathogens, 36 
stimulate the immune system, enhance digestion, increase yield and quality of animal proteins 37 
(Vohara et al., 2016). 38 
 39 
A key probiotic group are yeasts such as Saccharomyces cerevisiae which is approved for human use 40 
by The European Food Safety Authority (Vohara et al., 2016). Mannan oligosaccharide is derived 41 
from the cell wall of S. cerevisiae yeast which contains both mannan proteins and complex 42 
carbohydrates including β-glucans. It has been termed a nutricine, meaning it has no direct nutritive 43 
value but maintains intestinal digestive and absorptive functions, thus improving the health and 44 
performance of farmed animals (Halas and Nochta, 2012). The objective of this study is to evaluate if 45 
supplementing MOS to housed dairy cows prepartum affects colostrum IgG concentration, quantity 46 
and subsequent calf performance. 47 
 48 
Material and methods 49 
Experimental design 50 
In total, 80 Holstein cross Friesian cows (no heifers) were randomly assigned at point of drying off, 51 
over a 6-month period, by previous lactation number and yield into a treatment (MOS) and control (C) 52 
group in a double blind feeding trial. Cows were housed throughout the trial period in the same 53 
building split into two sections. 54 
 55 
A standard dry cow total mixed ration (Table 1) was fed ad libitum from drying off until point of 56 
calving. The control group received a standard commercial dry cow supplement (www.Scotmin.com) 57 
without MOS and the treatment group received the same supplement with MOS (Table 2). The 58 
mineral supplements were top-dressed at a rate of 150 g/head daily as fresh feed was delivered. The 59 
treatment provided 2 g/cow per day of MOS for a minimum of 4 weeks pre-calving as recommended 60 
by the manufacturer. Cows were moved from the cubicles to ensure they consumed mineral 61 
supplement at the same time every day. 62 
 63 
Table 1 Calculated composition of prepartum TMR diet 64 
 65 
 66 
 67 
 68 
 69 
 70 
 71 
 72 
 73 
 74 
 75 
 76 
 77 
 78 
 79 
 80 
 81 
1  TMR formulation on per cow basis then multiplied up by number of cows and fed ad libitum to all 82 
cows on trial. 83 
2  Calculated values. 84 
 85 
Table 2 Specification of dry cow mineral 1 , 2 , 3 (as received) 86 
Animal details ¹ 
Weight (Kg) 690 
Fat mobilisation change (kg/day) 0.50 
Feeding plan ² (kg) 
Molasses   
Megastart Pre Calver Mineral   
Straw -Wheat   
Second cut silage   
Calcined Magnesite  
Hipro soya Meal  
Myerscough blend 
1.60  
0.20  
5.00  
18.00  
0.08  
0.75 
1.50 
Nutrients ³ 
DM intake (kg/d)   
Forage DM (kg/d)   
ME (M/D)   
Protein (%DM)   
MP -N (g/d)   
MP -E (g/d)   
MP (limiting) (% req)   
Microbial CP (% N/E)   
Starch (%DM)   
Sugar (%DM)   
Starch plus Sugar (%DM)   
NDF (%DM) 
12.4  
9.0  
9.7  
13.4  
1157  
1017  
152  
125  
2.9  
10.5  
13.4  
49.1 
 87 
 88 
 89 
 90 
 91 
  92 
MOS=mannan oligosaccharide. 93 
1  MOS added at 1.33% in the above to the treatment group. 94 
2  Additional trace minerals included; cobalt, copper, iodine, manganese, selenium, zinc and vitamins 95 
A, D3, E and B12. 96 
3  Chemical composition as legally declared and supplied by Scotmin Nutrition (www.Scotmin.com). 97 
 98 
Sample collection 99 
Colostrum samples were obtained from 59 of the 80 Holstein-Friesian dairy cows, as any cows that 100 
calved unattended or where the calf was known to have suckled, were not sampled. Cows were 101 
milked out of colostrum using a Fullwood® (Fullwood Ltd, Ellesmere, Shropshire, UK) mobile 102 
milking machine and calibrated milking vessel in a crush close to calving pen within 40 min of 103 
calving. This allowed time for milk let-down to be stimulated and cow to calf bonding to occur but 104 
colostrum removal took place prior to calf suckling. 105 
 106 
Total colostrum weight was measured, six samples (30 ml) were taken and once temperature of the 107 
colostrum reached 22°C the density was measured using a Volac® (Volac International Ltd Royston, 108 
Hertfordshire, UK) colostrometer. Samples were frozen (−20°C) following cooling and stored for IgG 109 
concentration. The remaining colostrum was bottled and immediately fed to the corresponding calf. 110 
 111 
At birth, the sex of each calf and weight were recorded. Calves were weighed in a Ritchie® (Ritchie 112 
Agriculture, Forfar, Angus, UK) mobile weigh crate. The weight of calves was taken on transfer to an 113 
individual pen and fortnightly until 2 weeks post weaning. 114 
 115 
Chemical composition ² (%) 
Calcium   
Phosphorus  
Magnesium  
Sodium   
Chlorine   
Potassium   
Sulphur   
Yeast cell wall material (MOS)  
 
1.30  
4.00  
20.00  
12.30  
19.00  
0.08  
0.08  
1.33  
 
Laboratory analysis 116 
Whole colostrum was analysed for IgG by single radial immunodiffusion (SRID) using BOV 117 
IgGIDRing® Test kit (IDBiotech; ImmunoDiffusion Biotechnologies, Issoire, France). Total mass of 118 
immunoglobulin produced was calculated by multiplying IgG concentration (g/l) by milk volume (l) 119 
(Osaka et al. 2014). 120 
 121 
Statistical analysis 122 
Data analysis was carried out using Minitab® 17 statistical software package (www.minitab.com, 123 
2012). Residual values were checked for normality. Parametric data were examined using ANOVA 124 
tests; whereas non-parametric data were examined using Kruskal–Wallis tests. 125 
 126 
Results 127 
Colostrum immunoglobulin G and quantity 128 
There was a wide variation in colostrum IgG concentration in both trial groups ranging from 19.5 to 129 
85.1 g/l with an overall average of 47.8 g/l (SEM±3.8). Treatment did not affect colostrum IgG 130 
concentration (P=0.08) with mean IgG of 42.7 g/l (SEM±4.9) for MOS and control IgG 53.7 g/l 131 
(SEM±5.8). 132 
 133 
Mean colostrum produced immediately post-calving in the MOS group was 7.5 kg (SEM±0.69) v. 134 
control 5.6 kg (SEM±0.43). Mannan oligosaccharide significantly increased the weight of colostrum 135 
produced by an average of 1.96 kg per cow (P=0.02). 136 
 137 
Despite increased volume of colostrum produced by MOS fed cows, there was no effect (P=0.76) on 138 
the total mass of immunoglobulin produced when compared with control cows (MOS 288 total IgG, 139 
SEM±53.4 v. 276 total IgG, SEM±55.3). 140 
 141 
Calf performance 142 
There were 16 male and 13 female calves in MOS group and 10 males and 9 female calves in control 143 
group. Average birth weight of MOS fed calves was 44.9 kg (SEM±1.1) v. control 43.5 kg 144 
(SEM±1.0). Birth weights (P=0.43), 8 week weaning weights (P=0.42) and gain from birth to 145 
weaning (P=0.75) did not differ between treatments. 146 
 147 
Discussion 148 
The current study found that supplementation prepartum of MOS derived from S. cerevisiae, had no 149 
effect on colostrum IgG concentration. This work supports the findings of Franklin et al. (2005) who 150 
reported similar concentrations and levels of variation in colostral IgG but no difference in cows fed 151 
MOS (35.5 to 52.2 g/l, SEM±7.1 to 10.8) and control diet (33.8 to 60.6 g/l, SEM±6.6 to 13.8). The 152 
wide variation found in IgG concentration may explain the absence of treatment effect in both these 153 
studies. 154 
 155 
Lactation number has been identified as a potential source of variation particularly in cows entering 156 
third lactation and above (Conneely et al., 2013). This was confirmed by Franklin et al. (2005) 157 
reporting significantly higher colostral IgG concentration, regardless of treatment, for cows in third 158 
lactation or greater compared with second lactation. History of previous mammary quarter diseases 159 
may be a key influencing factor in IgG concentrations. Baumrucker et al. (2014) identified that any 160 
quarter within the udder can produce different concentrations and mass of IgG in first-milked 161 
colostrum. Cows in third lactation or above may exhibit larger fluctuations in IgG due to previous 162 
mammary infections damaging the mammary epithelium (Baumrucker et al., 2014). In this study 163 
more than two-third of cows sampled were in their third lactation or above for both MOS and control 164 
groups and likely to be responsible for the high level of variation in colostral IgG concentration. 165 
 166 
Time interval from calving to first milking of colostrum is another source of variation in IgG 167 
concentrations. Conneely et al. (2013) found significantly lower IgG in cows milked post 9 h from 168 
calving. All results in this present study were from cows milked within first hour after calving 169 
therefore the variation found is unlikely to be due to time interval from calving to first milking. 170 
 171 
In this study feeding MOS prepartum increased the quantity of colostrum produced. Franklin et al. 172 
(2005) conversely found no significant change in the quantity of colostrum due to treatment (MOS 173 
6.5±1.6 to 7.1±1.1 kg v. control 6.4±1.2 to 8.1±1.3 kg). The potential mode of action may involve the 174 
stimulating effect of MOS on the innate immune system, increasing the production of mannose-175 
binding proteins which enhances phagocytosis (Franklin et al., 2005). During the vulnerable last 4 176 
weeks prepartum Franklin et al. (2005) found that feeding MOS influenced the immune system of the 177 
cow as demonstrated by increased rotavirus titres in serum and colostrum in previously unvaccinated 178 
cows. It could be hypothesised that this enhancement of the immune system, both specific and innate, 179 
may lead to enhanced colostrum production levels due to more efficient metabolism. 180 
 181 
Several studies have emphasised that it is not just the quality or quantity of colostrum consumed that 182 
is essential but the mass of immunoglobulin intake that is important. Osaka et al. (2014) found that the 183 
total mass of IgG consumed affected the serum level of IgG in calves. The total mass of 184 
immunoglobulin produced in the present experiment was not significantly different between MOS and 185 
control, indicating that mass immunoglobulin intake would be similar for both groups of calves when 186 
left on their dams for first 24 h and therefore unlikely to affect future calf health and performance.  187 
Previous studies have examined the effect on calf performance of including MOS in milk replacers. In 188 
this trial no differences in calf performance were found in MOS fed calves. Similarly, Terre’ et al. 189 
(2007) found no difference in overall average daily gain or weaning weight of calves fed MOS via the 190 
milk replacer but did see an initial effect on starter feed intake. Feed intake was not recorded in this 191 
trial and calves had access to the same feeds and forages. 192 
 193 
Conclusions 194 
Mannan oligosaccharide derived from S. cerevisiae does not affect IgG concentration or the total IgG 195 
mass but does increase the weight of colostrum produced. Further studies on the effect of MOS on 196 
prepartum cow health particularly metabolic and immune status and eliminating or reducing the 197 
influence of variables such as previous lactation number and history of mammary disease are 198 
warranted. 199 
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